tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Positive Outlook for Lucid Diagnostics: Buy Rating Affirmed Amid Growth in EsoGuard Test Volumes and Strong Financial Management
PremiumRatingsPositive Outlook for Lucid Diagnostics: Buy Rating Affirmed Amid Growth in EsoGuard Test Volumes and Strong Financial Management
29d ago
Lucid Diagnostics Reports Q3 2025 Financial Results
Premium
Company Announcements
Lucid Diagnostics Reports Q3 2025 Financial Results
29d ago
Lucid Diagnostics’ Earnings Call: Strategic Wins Amid Challenges
Premium
Company Announcements
Lucid Diagnostics’ Earnings Call: Strategic Wins Amid Challenges
30d ago
Lucid Diagnostics Announces Public Stock Offering
PremiumCompany AnnouncementsLucid Diagnostics Announces Public Stock Offering
3M ago
Morning Movers: Oracle powers market higher following ‘blowout’ Q1 results
Premium
The Fly
Morning Movers: Oracle powers market higher following ‘blowout’ Q1 results
3M ago
Lucid Diagnostics 25M share Spot Secondary priced at $1.00
Premium
The Fly
Lucid Diagnostics 25M share Spot Secondary priced at $1.00
3M ago
Positive Outlook on Lucid Diagnostics’ EsoGuard Test Driven by Clinician Support and Potential Medicare Coverage
PremiumRatingsPositive Outlook on Lucid Diagnostics’ EsoGuard Test Driven by Clinician Support and Potential Medicare Coverage
3M ago
Positive Outlook on Lucid Diagnostics Driven by EsoGuard’s Clinical Efficacy and Potential Medicare Coverage
Premium
Ratings
Positive Outlook on Lucid Diagnostics Driven by EsoGuard’s Clinical Efficacy and Potential Medicare Coverage
3M ago
Lucid Diagnostics Earnings Call: Optimism Amid Challenges
Premium
Company Announcements
Lucid Diagnostics Earnings Call: Optimism Amid Challenges
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100